- Home
- CSTE vs VNRX Comparison
CSTE vs VNRX Comparison
Compare CSTE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- VNRX
- Stock Information
- Founded
- CSTE 1987
- VNRX N/A
- Country
- CSTE Israel
- VNRX United States
- Employees
- CSTE N/A
- VNRX N/A
- Industry
- CSTE Building Materials
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CSTE Industrials
- VNRX Health Care
- Exchange
- CSTE Nasdaq
- VNRX Nasdaq
- Market Cap
- CSTE 61.9M
- VNRX 52.4M
- IPO Year
- CSTE 2012
- VNRX N/A
- Fundamental
- Price
- CSTE $1.87
- VNRX $0.75
- Analyst Decision
- CSTE Strong Buy
- VNRX Strong Buy
- Analyst Count
- CSTE 1
- VNRX 5
- Target Price
- CSTE $6.00
- VNRX $3.88
- AVG Volume (30 Days)
- CSTE 174.0K
- VNRX 156.5K
- Earning Date
- CSTE 08-06-2025
- VNRX 08-13-2025
- Dividend Yield
- CSTE N/A
- VNRX N/A
- EPS Growth
- CSTE N/A
- VNRX N/A
- EPS
- CSTE N/A
- VNRX N/A
- Revenue
- CSTE $424,487,000.00
- VNRX $1,308,361.00
- Revenue This Year
- CSTE N/A
- VNRX $563.72
- Revenue Next Year
- CSTE $6.60
- VNRX $160.43
- P/E Ratio
- CSTE N/A
- VNRX N/A
- Revenue Growth
- CSTE N/A
- VNRX 64.16
- 52 Week Low
- CSTE $1.62
- VNRX $0.40
- 52 Week High
- CSTE $6.54
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- CSTE 50.62
- VNRX 55.55
- Support Level
- CSTE $1.75
- VNRX $0.71
- Resistance Level
- CSTE $1.80
- VNRX $0.79
- Average True Range (ATR)
- CSTE 0.13
- VNRX 0.06
- MACD
- CSTE 0.02
- VNRX -0.00
- Stochastic Oscillator
- CSTE 64.86
- VNRX 71.43
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.